Literature DB >> 24633831

Para-aortic lymph node sampling in pancreatic head adenocarcinoma.

L Schwarz1, R M Lupinacci, M Svrcek, M Lesurtel, M Bubenheim, H Vuarnesson, P Balladur, F Paye.   

Abstract

BACKGROUND: The significance of positive para-aortic nodes in patients with resectable pancreatic carcinoma is unclear. This study sought to evaluate the accuracy of intraoperative detection and prognostic significance of these lymph nodes in patients with resected adenocarcinoma of the pancreatic head.
METHODS: From 2000 to 2010, para-aortic node sampling was performed prospectively in all patients before pancreatoduodenectomy. Frozen sections were created and nodes categorized as positive or negative for metastases. Surgeons were blinded to the frozen-section results. This was followed by standard histopathological assessment of corresponding paraffin-embedded, haematoxylin and eosin-stained material. Nodes considered uninvolved by this analysis were examined immunohistochemically for micrometastases.
RESULTS: A total of 111 consecutive patients were included, with a median follow-up of 20·8 (range 1·5-126) months. The 1-, 2- and 5-year overall survival (OS) and disease-free survival (DFS) rates were 73·6, 54·0 and 24·7 per cent, and 51·8, 28·1 and 18·8 per cent respectively. Para-aortic node involvement was always associated with peripancreatic lymph node metastasis, and was detected by frozen-section analysis in 12 patients and by haematoxylin and eosin staining in 17. Sensitivity and specificity of frozen-section examination for detecting para-aortic lymph node metastases were 71 and 100 per cent respectively. Median OS for patients with and without para-aortic node involvement on frozen-section analysis was 9·7 versus 28·5 months respectively (P = 0·012), and 15·7 versus 27·2 months (P = 0·050) when assessed by haematoxylin and eosin staining. Median DFS for patients with and without para-aortic node involvement on frozen-section examination was 5·6 versus 12·9 months respectively (P = 0·041), and 8·4 versus 12·9 months (P = 0·038) for haematoxylin and eosin analysis. The presence of micrometastases in para-aortic nodes was not significantly associated with altered OS or DFS.
CONCLUSION: Para-aortic node sampling with frozen-section examination detects distant lymphatic involvement reliably. It should be performed systematically. When metastases are found, they should be considered a contraindication to pancreatic resection.
© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24633831     DOI: 10.1002/bjs.9444

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  32 in total

1.  Feasibility and reliability of pancreatic cancer staging using a new confocal non-fluorescent microscopy probe: a double-blind study in rats.

Authors:  Cherif Akladios; Vivian De Ruijter; Sylvana Perretta; Marc Aprahamian; Mihaela Ignat; Veronique Lindner; Gerlinde Averous; Bernard Dallemagne; Jacques Marescaux
Journal:  Surg Endosc       Date:  2016-06-28       Impact factor: 4.584

Review 2.  Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Nadia Peparini
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

3.  Pancreatectomy with Vascular Resection After Neoadjuvant FOLFIRINOX: Who Survives More Than a Year After Surgery?

Authors:  Laurent Sulpice; Olivier Turrini; Jonathan Garnier; Fabien Robin; Jacques Ewald; Ugo Marchese; Damien Bergeat; Karim Boudjema; Jean-Robert Delpero
Journal:  Ann Surg Oncol       Date:  2021-01-18       Impact factor: 5.344

Review 4.  Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

Authors:  Daniel Åkerberg; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 5.  Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features.

Authors:  Christos Agalianos; Nikolaos Gouvas; Kleo Papaparaskeva; Christos Dervenis
Journal:  HPB (Oxford)       Date:  2016-06-03       Impact factor: 3.647

6.  Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.

Authors:  Masayuki Sho; Yoshiaki Murakami; Fuyuhiko Motoi; Sohei Satoi; Ippei Matsumoto; Manabu Kawai; Goro Honda; Kenichiro Uemura; Hiroaki Yanagimoto; Masanao Kurata; Takumi Fukumoto; Takahiro Akahori; Shoichi Kinoshita; Minako Nagai; Satoshi Nishiwada; Michiaki Unno; Hiroki Yamaue; Yoshiyuki Nakajima
Journal:  J Gastroenterol       Date:  2014-10-24       Impact factor: 7.527

7.  Inferoposterior duodenal approach for laparoscopic pancreaticoduodenectomy.

Authors:  Xiao-Ming Wang; Wei-Dong Sun; Ming-Hua Hu; Gua-Nan Wang; Ya-Qi Jiang; Xiao-San Fang; Meng Han
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

8.  The Additional Value of Laparoscopic Ultrasound to Staging Laparoscopy in Patients with Suspected Pancreatic Head Cancer.

Authors:  Gijs A Looijen; Bobby K Pranger; Koert P de Jong; Jan Pieter Pennings; Vincent E de Meijer; Joris I Erdmann
Journal:  J Gastrointest Surg       Date:  2018-03-12       Impact factor: 3.452

Review 9.  Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis.

Authors:  Lennart B van Rijssen; Poorvi Narwade; Nadine C M van Huijgevoort; Dorine S J Tseng; Hjalmar C van Santvoort; Isaac Q Molenaar; Hanneke W M van Laarhoven; Casper H J van Eijck; Olivier R C Busch; Marc G H Besselink
Journal:  HPB (Oxford)       Date:  2016-05-27       Impact factor: 3.647

10.  Incidence and prognostic impact of para-aortic lymph nodes metastases during pancreaticoduodenectomy for peri-ampullary cancer.

Authors:  Gennaro Nappo; Domenico Borzomati; Giuseppe Perrone; Sergio Valeri; Michela Amato; Tommasangelo Petitti; Roberto Coppola
Journal:  HPB (Oxford)       Date:  2015-09-03       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.